Biological therapies for asthma
Five to 10% of asthma patients remain symptomatic and/or have asthma attacks despite adequate inhaled and systemic therapy. Eosinophilic, type 2 airway inflammation is seen in half of these patients with severe asthma. There is now convincing evidence that type 2 inflammation drives susceptibility t...
| Päätekijät: | , |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Book section |
| Kieli: | English |
| Julkaistu: |
Elsevier
2021
|